title: Systemic treatment with epidermal growth factor but not insulin-like growth factor I decreases the involution of the prostate in castrated rats.
abstract: Epidermal growth factor (EGF) and insulin-like growth factor I (IGF-I) are strong inducers of proliferation to prostate cells cultured in serum-free medium. Accordingly we wanted to study the growth of the prostate gland in castrated rats after treatment with EGF, IGF-I and testosterone. Castrated Wistar rats were treated with growth factors (EGF 35 microg/rat per day; IGF-I 350 microg/rat per day) or testosterone (2 mg/rat per day) for 3 days either immediately after or 10 days after castration. Prostate tissue was examined by stereological and immunohistochemical techniques and by enzyme-linked immunosorbent assay (ELISA). Treatment with EGF inhibited the involution of the prostate (P < 0.05), whereas treatment with IGF-I did not affect the prostate involution as compared to castrated controls. EGF treatment significantly increased the endogenous rat EGF in the ventral prostate, but cellular proliferation was not affected. Testosterone treatment increased the weight of the prostate, by increase of all tissue components of the prostate, and significantly increased cellular proliferation. Systemic administration of EGF but not IGF-I decreased the involution of the rat prostate induced by castration. Compared with testosterone, the effects of EGF treatment on the prostate involution were moderate, and the effects of EGF were not related to cellular proliferation.
authors.affiliation: Department of Clinical Biochemistry-KH, Aarhus University Hospital, Denmark. ntorring@hotmail.com
authors.forename: N
authors.initials: N
authors.lastname: Tørring
authors.forename: L
authors.initials: L
authors.lastname: Vinter-Jensen
authors.forename: F B
authors.initials: FB
authors.lastname: Sørensen
authors.forename: A
authors.initials: A
authors.lastname: Flyvbjerg
authors.forename: E
authors.initials: E
authors.lastname: Nexø
mesh_terms: D000818:Animals; D002455:Cell Division / Q000187:drug effects; D004815:Epidermal Growth Factor / Q000032:analysis / Q000494:pharmacology*; D012739:Gonadal Steroid Hormones / Q000494:pharmacology; D007334:Insulin-Like Growth Factor I / Q000378:metabolism / Q000494:pharmacology*; D008297:Male; D009919:Orchiectomy; D009929:Organ Size; D011467:Prostate / Q000737:chemistry / Q000187:drug effects* / Q000473:pathology*; D051381:Rats; D017208:Rats, Wistar; D012669:Seminal Vesicles / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D013739:Testosterone / Q000494:pharmacology; D013997:Time Factors
chemical_list: D012739:Gonadal Steroid Hormones; D013739:Testosterone; D004815:Epidermal Growth Factor; D007334:Insulin-Like Growth Factor I